KIVA Confections Terra Peppermint Pattie Bites
Detroit Fudge Company Barracuda Bar
“I like to think of myself as a bit of ganga guru, and in the edibles department, I’d pretty much recommend anything made by Kiva. If I had to pick one, I’d probably go with their Peppermint Pattie Bites. They’re only one gram of sugar each, but the [milk] chocolate is actually really good, and the peppermint doesn’t taste fake. They also have no aftertaste, which I think is usually a big ask for any chocolate-cannabis edibles, and not all manufacturers nail it.
Terra Peppermint Pattie bites, $20 per tin of 20 5mg pieces, purchased at Dunegrass, Manistee. dunegrass.co. Detroit Fudge Company Dark Chocolate Barracuda Bar, currently on sale for $15.90, for a single hybrid-strain bar of 20 5mg pieces, available at Riverside Provisioning, Grayling or Kalkaska. www.rsmeds.com
Actually, another one that really does chocolate well is Detroit Fudge Company — their [Dark Chocolate] Barracuda Bar [made with 65 percent high-quality Belgian chocolate] is insanely rich and smooth and something I would eat even if it didn’t have THC in it. I’m going to pack a bar to make grown-up S’mores on a backpacking trip some friends and I are planning this summer.
Chill Out Fast-Acting Drink Enhancer (pictured above)
“I prefer edibles because I don’t smoke, and I like knowing exactly how much THC from which strain I’m getting, where it’s sourced, etc. I think legalization has been amazing for people who like or need to make informed choices about what’s going in their bodies. What I don’t like about edibles is that they can take up to an hour or so to kick in. When I’m stressed or aggravated after a 10-hour day on the phone and in meetings, I don’t want to wait another hour after I get home to relax. It sounds high maintenance, but seriously, that’s exactly why happy hour exists for drinkers, right?
Although progressive policies and indigenous-cultivation startups in places like Australia, the U.K., Germany, Israel, Croatia, Poland, Columbia, and the Netherlands are contributing to the global growth, the region driving it hardest and fastest is North America, with a 2020 revenue share of 91.1 percent.
Lume Cannabis Co.
“As a 40-something mom of two energetic kids under age six, with a demanding professional job, I tend to avoid indica strains, which are more for relaxation and better sleep. I don’t really have a problem slowing down; I do have a problem finding enough energy to rev up to clean my house, work in the yard, play with my kids, prep meals for the week, etc. I’ve bought these Move [sativa strain] gummies several times, in several flavors, and I have loved them all.
Long gone are the days of needle-sized joints of shake, or funky-tasting brownies containing indeterminate loads of THC (or other mystery substances). Tech, government, and assorted weed-business visionaries have come together at this moment in history to deliver a breadth of reliably measured and seriously tasty (and even some tasteless) cannabis products, now designed to deliver specific kinds of high individual users might seek.
This work was funded in part by a grant from the National Institute on Drug Abuse to MB (1R01DA034699-01).
34. Bidwell LC, Mueller R, YorkWilliams SL, Hagerty S, Bryan AD, Hutchison KE. A novel observational method for assessing acute responses to cannabis: preliminary validation using legal market strains. Cannabis Cannabinoid Res. (2018) 3:35–44. doi: 10.1089/can.2017.0038
18. Miettunen J, Törmänen S, Murray GK, Jones PB, Mäki P, Ebeling H, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry. (2008) 192:470–1. doi: 10.1192/bjp.bp.107.045740
Discussion: There is substantial heterogeneity across studies in dose, method of drug delivery, length of treatment, patient age, whether patients with cannabis use/CUD were included or excluded, and whether patients were using antipsychotic medication.
22. Henquet C, van Os J, Kuepper R, Delespaul P, Smits M, Campo JA, et al. Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry. (2010) 196:447–53. doi: 10.1192/bjp.bp.109.072249